ATE138383T1 - Glycolipid-derivate - Google Patents
Glycolipid-derivateInfo
- Publication number
- ATE138383T1 ATE138383T1 AT93111255T AT93111255T ATE138383T1 AT E138383 T1 ATE138383 T1 AT E138383T1 AT 93111255 T AT93111255 T AT 93111255T AT 93111255 T AT93111255 T AT 93111255T AT E138383 T1 ATE138383 T1 AT E138383T1
- Authority
- AT
- Austria
- Prior art keywords
- derivatives
- glycolipide
- chem
- agents
- metastasis
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
- C07H15/18—Acyclic radicals, substituted by carbocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
- A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes or liposomes coated or grafted with polymers
- A61K9/1272—Non-conventional liposomes, e.g. PEGylated liposomes or liposomes coated or grafted with polymers comprising non-phosphatidyl surfactants as bilayer-forming substances, e.g. cationic lipids or non-phosphatidyl liposomes coated or grafted with polymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Molecular Biology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Dispersion Chemistry (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Epidemiology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Immunology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Saccharide Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP18800192 | 1992-07-15 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE138383T1 true ATE138383T1 (de) | 1996-06-15 |
Family
ID=16215909
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT93111255T ATE138383T1 (de) | 1992-07-15 | 1993-07-15 | Glycolipid-derivate |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US5369096A (de) |
| EP (1) | EP0579196B1 (de) |
| JP (1) | JPH0680687A (de) |
| AT (1) | ATE138383T1 (de) |
| CA (1) | CA2100412A1 (de) |
| DE (1) | DE69302767T2 (de) |
| DK (1) | DK0579196T3 (de) |
| ES (1) | ES2090790T3 (de) |
Families Citing this family (39)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5326752A (en) * | 1991-11-27 | 1994-07-05 | Glycomed Incorporated | Substituted lactose and lactosamine derivatives as cell adhesion inhibitors |
| JPH08500820A (ja) * | 1992-06-29 | 1996-01-30 | グライコメッド インコーポレイテッド | 細胞接着インヒビターとしての置換されたラクトース誘導体 |
| US5591835A (en) * | 1992-06-29 | 1997-01-07 | Glycomed Incorporated | Substituted lactose derivatives |
| DE4408248A1 (de) * | 1994-03-11 | 1995-09-14 | Hoechst Ag | Physiologisch verträgliche und physiologisch abbaubare Kohlenhydrat-Mimetika, ein Verfahren zur Herstellung und ihre Verwendung |
| JPH0899989A (ja) * | 1994-09-30 | 1996-04-16 | Akira Hasegawa | 新規糖脂質誘導体およびその製造用中間体 |
| WO1996041636A1 (en) * | 1995-06-13 | 1996-12-27 | The Nisshin Oil Mills, Ltd. | Antiasthmatic agent |
| HUP9801805A3 (en) * | 1995-06-29 | 2002-01-28 | Novartis Ag | Diglycosylated 1,2-diols as mimetics of sialyl-lewis x and sialyl-lewis a |
| AU6485496A (en) * | 1995-07-14 | 1997-02-18 | Glycotech Corp. | Compounds and methods for treatment of egf receptor associated cancers and purification of the egf receptor |
| US5876715A (en) * | 1995-08-17 | 1999-03-02 | The Biomembrane Institute | Antibodies that bind novel carbohydrate ligands (myelorollins) that cause E-selectin dependent cell rolling, and uses thereof |
| CA2316041A1 (en) * | 1997-12-30 | 1999-07-08 | Pam Fredman | Galactosylceramide, glucosylceramide, lactosylceramide, and specific catchers therefor for use in the prophylaxis or therapy of prediabetes, diabetes and/or associated complications |
| JP2001352982A (ja) * | 2000-06-12 | 2001-12-25 | Shimadzu Corp | 核酸合成法 |
| JP5183010B2 (ja) | 2002-05-16 | 2013-04-17 | グリコミメティクス, インコーポレイテッド | セレクチンによって媒介される機能を阻害するための化合物および方法 |
| AU2003245595A1 (en) * | 2002-07-03 | 2004-01-23 | Glycomimetics, Inc. | Compositions and methods for diagnosis and therapy of medical conditions involving angiogenesis |
| US20040219158A1 (en) * | 2003-05-02 | 2004-11-04 | Glycomimetics, Inc. | Compositions and methods for diagnosis and therapy of medical conditions involving infection with pseudomonas bacteria |
| DE602004011272T2 (de) * | 2003-11-19 | 2008-12-24 | Glycomimetics, Inc. | Spezifischer antagonist sowohl für e- als auch p-selektine |
| CA2546784A1 (en) * | 2003-11-19 | 2005-06-16 | Glycomimetics, Inc. | Glycomimetic antagonists for both e- and p-selectins |
| US20090036386A1 (en) * | 2005-05-25 | 2009-02-05 | Glycomimetics, Inc | Heterobifunctional compounds for selectin inhibition |
| WO2007021721A2 (en) * | 2005-08-09 | 2007-02-22 | Glycomimetics, Inc. | Glycomimetic inhibitors of the pa-il lectin, pa-iil lectin or both the lectins from pseudomonas |
| SI2264043T1 (en) | 2005-09-02 | 2018-01-31 | Glycomimetics, Inc. | HETEROBIFUNCTIONAL PAN-SELECTINE INHIBITORS |
| US20090176717A1 (en) * | 2006-06-01 | 2009-07-09 | Glycomimetics, Inc. | Galactosides and thiodigalactosides as inhibitors of pa-il lectin from pseudomonas |
| US7964569B2 (en) | 2006-10-12 | 2011-06-21 | Glycomimetics, Inc. | Glycomimetic replacements for hexoses and N-acetyl hexosamines |
| WO2008100453A1 (en) * | 2007-02-09 | 2008-08-21 | Glycomimetics, Inc. | Methods of use of glycomimetics with replacements for hexoses and n-acetyl hexosamines |
| US8039442B2 (en) * | 2007-07-18 | 2011-10-18 | Glycomimetics, Inc. | Compounds and methods for treatment of sickle cell disease or complications associated therewith |
| US8895510B2 (en) | 2008-04-08 | 2014-11-25 | Glycomimetics, Inc. | Pan-selectin inhibitor with enhanced pharmacokinetic activity |
| US8518896B2 (en) | 2008-06-13 | 2013-08-27 | Glycomimetics, Inc. | Treatment of cancers of the blood using selected glycomimetic compounds |
| AU2010241807B2 (en) * | 2009-05-01 | 2014-08-14 | Glycomimetics, Inc. | Heterobifunctional inhibitors of E-selectins and CXCR4 chemokine receptors |
| US8921328B2 (en) | 2010-09-14 | 2014-12-30 | Glycomimetics, Inc. | E-selectin antagonists |
| EP2794626B3 (de) | 2011-12-22 | 2020-08-05 | GlycoMimetics, Inc. | E-selectin-antagonistenverbindungen |
| HUE038423T2 (hu) | 2012-12-07 | 2018-10-29 | Glycomimetics Inc | E-szelektin antagonistákat felhasználó vegyületek, készítmények és eljárások vérképzõ sejtek mobilizációjára |
| CN107108679B (zh) | 2014-12-03 | 2020-10-23 | 糖模拟物有限公司 | E-选择蛋白和cxcr4趋化因子受体的异双官能抑制剂 |
| WO2017127422A1 (en) | 2016-01-22 | 2017-07-27 | Glycomimetics, Inc. | Glycomimetic inhibitors of pa-il and pa-iil lectins |
| US11291678B2 (en) | 2016-03-02 | 2022-04-05 | Glycomimetics, Inc | Methods for the treatment and/or prevention of cardiovascular disease by inhibition of E-selectin |
| US11433086B2 (en) | 2016-08-08 | 2022-09-06 | Glycomimetics, Inc. | Combination of T-cell checkpoint inhibitors with inhibitors of e-selectin or CXCR4, or with heterobifunctional inhibitors of both E-selectin and CXCR4 |
| BR112019006642A2 (pt) | 2016-10-07 | 2019-07-02 | Glycomimetics Inc | antagonistas multiméricos de e-selectina altamente potentes |
| CA3054605A1 (en) | 2017-03-15 | 2018-09-20 | Glycomimetics, Inc. | Galactopyranosyl-cyclohexyl derivatives as e-selectin antagonists |
| EP3717013A1 (de) | 2017-11-30 | 2020-10-07 | GlycoMimetics, Inc. | Verfahren zur mobilisierung von knochenmarkinfiltrierenden lymphozyten und deren verwendung |
| US11548908B2 (en) | 2017-12-29 | 2023-01-10 | Glycomimetics, Inc. | Heterobifunctional inhibitors of E-selectin and galectin-3 |
| AU2019230013A1 (en) | 2018-03-05 | 2020-09-10 | Glycomimetics, Inc. | Methods for treating acute myeloid leukemia and related conditions |
| US11845771B2 (en) | 2018-12-27 | 2023-12-19 | Glycomimetics, Inc. | Heterobifunctional inhibitors of E-selectin and galectin-3 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2509313A1 (fr) * | 1981-07-08 | 1983-01-14 | Choay Sa | Derives de 3-fucosyl-n-acetyl lactosamine, leur preparation et leurs applications biologiques |
| US4762800A (en) * | 1984-04-26 | 1988-08-09 | Sloan-Kettering Institute For Cancer Research | Monoclonal antibodies to cell surface antigens of human teratocarcinomas |
| US5002759A (en) * | 1989-07-25 | 1991-03-26 | Colgate-Palmolive Company | Oligosaccharide inhibition of Streptococcus pyogenes adhesion |
| WO1991019501A1 (en) * | 1990-06-15 | 1991-12-26 | Cytel Corporation | Intercellular adhesion mediators |
| US5143712A (en) * | 1990-07-30 | 1992-09-01 | Glycomed Incorporated | Method of determining a site of inflammation utilizing elam-1 ligands |
| US5211937A (en) * | 1990-07-30 | 1993-05-18 | Glycomed Incorporated | Method of determining a site of inflammation utilizing elam-1 ligands |
| NZ240316A (en) * | 1990-10-25 | 1996-12-20 | Univ Michigan | Compound for treating disease mediated by the elaboration of elam-1 on endothelial cells |
-
1993
- 1993-07-13 CA CA002100412A patent/CA2100412A1/en not_active Abandoned
- 1993-07-15 US US08/091,252 patent/US5369096A/en not_active Expired - Fee Related
- 1993-07-15 ES ES93111255T patent/ES2090790T3/es not_active Expired - Lifetime
- 1993-07-15 JP JP5175019A patent/JPH0680687A/ja active Pending
- 1993-07-15 DE DE69302767T patent/DE69302767T2/de not_active Expired - Fee Related
- 1993-07-15 DK DK93111255.1T patent/DK0579196T3/da active
- 1993-07-15 AT AT93111255T patent/ATE138383T1/de active
- 1993-07-15 EP EP93111255A patent/EP0579196B1/de not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| US5369096A (en) | 1994-11-29 |
| DE69302767T2 (de) | 1996-11-14 |
| ES2090790T3 (es) | 1996-10-16 |
| JPH0680687A (ja) | 1994-03-22 |
| EP0579196A1 (de) | 1994-01-19 |
| EP0579196B1 (de) | 1996-05-22 |
| DE69302767D1 (de) | 1996-06-27 |
| DK0579196T3 (da) | 1996-07-01 |
| CA2100412A1 (en) | 1994-01-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69302767D1 (de) | Glycolipid-Derivate | |
| ES2097653T3 (es) | Nuevos derivados de desoxigalactonojirimicina. | |
| HUT49860A (en) | Process for producing benzamide-type protease inhibitors | |
| ZA971714B (en) | Use of estrogen antagonists and estrogen agonists in inhibiting pathological conditions | |
| ATE61374T1 (de) | Diaminoandrostanderivate. | |
| ZA9710292B (en) | Atherosclerosis treatment | |
| MY111305A (en) | Wellbore fluid. | |
| ATE203020T1 (de) | Schwefel enthaltende heterocyclische verbindungen | |
| DE68922765D1 (de) | Substituierte Naphthalen-Verbindungen und diese enthaltende Flüssigkristall-Zusammensetzungen. | |
| HU9400491D0 (en) | Acyl-coenzyme-a=cholesterol acyl-transferase (acat) inhibitor tetrazole-carboxamide derivatives | |
| AU2321688A (en) | Compositions comprising 1-oxo- or thiohydrocarbyl substituted azacycloalkanes | |
| FI913067A0 (fi) | Bisfosfonsyraderivat, deras framstaellning och anvaendning. | |
| SI0668279T1 (en) | 6-Azaindole thromboxane synthase inhibitors | |
| MX170732B (es) | Composicion de derivados de succinimida y su uso | |
| DK0601191T3 (da) | Hidtil ukendt tetracyklisk forbindelse | |
| AU4953997A (en) | New histidine derivatives, preparation process, and their use as free antiradical agents | |
| NZ240404A (en) | Oxysulphonyl (thio)carbamate derivatives and pharmaceutical | |
| DE69103985D1 (de) | N-Alkylthiazolidinderivate. | |
| FR2541267B1 (de) | ||
| DE69333903D1 (de) | Optisch aktive 1-Phenylpyrrolidonderivate |